Page 3 - ப்ரிமியர் கல்வி நிகழ்வு கவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ரிமியர் கல்வி நிகழ்வு கவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ரிமியர் கல்வி நிகழ்வு கவனம் Today - Breaking & Trending Today

Johnson & Johnson's closely watched single-shot COVID-19 vaccine readout 'next week' as CFO sees 'robust data'

(iStock/Getty Images Plus/wildpixel)
While the world struggles with two-shot vaccine production as a handful of pharma companies try to make enough for almost the entire global population, a single-dose option from Johnson & Johnson has become a major hope in the fight against COVID-19.
Candidates from AstraZeneca-University of Oxford, Moderna and Pfizer-BioNTech all require two full doses, but with so many countries demanding more, supply is struggling to keep up. Many governments are now faced with tough choices, such as either delaying a second shot required for the full immune response needed according to data from clinical trials or getting one dose out to as many people as possible in the hope of partly protecting most rather than almost fully protecting all. ....

South Africa , Joe Wolk , University Of Oxford , Clinical Trials Summit , Premier Educational Event Focused , Decentralized Clinical , Big Pharma , Chief Financial Officer Joe Wolk , ஓஹோ வோல்க் , பல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட் , மருத்துவ சோதனைகள் உச்சிமாநாடு , ப்ரிமியர் கல்வி நிகழ்வு கவனம் , பெரியது பார்மா , தலைமை நிதி அதிகாரி ஓஹோ வோல்க் ,

FDA approves Boston Scientific's newest deep brain stimulator for Parkinson's disease

Jan 25, 2021 7:30am
The fourth generation of Boston Scientific s Vercise Genus system was approved for the stimulation of areas of the brain linked to the control of behavior and movement for patients with Parkinson’s disease who have responded to levodopa treatment, but whose symptoms are not adequately controlled with medication alone. (Boston Scientific)
Boston Scientific has obtained approval from the FDA for the fourth generation of its Vercise Genus deep brain stimulation system, allowing conditional use while within an MRI scanner.
Designed to treat the symptoms of Parkinson’s disease such as muscle slowness and tremors, the Vercise Genus family includes Bluetooth-enabled implantable pulse generators with both rechargeable and non-rechargeable models. ....

United States , Maulik Nanavaty , Boston Scientific , Vercise Genus , Clinical Trials Summit , Premier Educational Event Focused , Decentralized Clinical , Food And Drug Administration Fda , Deep Brain Stimulation , Medical Device , Parkinson 039s Disease , ஒன்றுபட்டது மாநிலங்களில் , ம Ul லிக் நானாவதி , போஸ்டன் அறிவியல் , மருத்துவ சோதனைகள் உச்சிமாநாடு , ப்ரிமியர் கல்வி நிகழ்வு கவனம் , ஆழமான மூளை ஸ்டிம்யுலேஶந் , மருத்துவ சாதனம் ,

TScan adds another $100M to the pot to as it plots new TCR cancer trials

(NIH)
TScan Therapeutics has raised a cool $100 million in a series C to start 2021 on the positive notes it rang throughout 2020.
Boston area-based TScan launched in July 2019 with the goal of identifying new targets for T-cell therapies in both blood cancers and solid tumors. It started off with $48 million and later inked a collaboration with its Big Pharma backer Novartis for research into kidney cancer.
Then, late last year, it took aim at COVID-19 turning its genome-based, high-throughput discovery platform for parsing T-cell receptors (TCRs) toward the coronavirus pandemic and how those immune cells react and inked a licensing agreement with Qiagen. ....

United States , Harvard University , Pitango Healthtech , David Southwell , Longwood Fund , Novartis Venture Fund , Big Pharma , Clinical Trials Summit , Premier Educational Event Focused , Decentralized Clinical , Bessemer Venture Partners , ஒன்றுபட்டது மாநிலங்களில் , கருப்பு பாறை , ஹார்வர்ட் பல்கலைக்கழகம் , டேவிட் தென்மேற்கு , லாங்வுட் நிதி , நோவர்த்திச் துணிகர நிதி , பெரியது பார்மா , மருத்துவ சோதனைகள் உச்சிமாநாடு , ப்ரிமியர் கல்வி நிகழ்வு கவனம் , பெஸ்ஸெமர் துணிகர கூட்டாளர்கள் ,

Vaccine ramp-up squeezes COVID-19 testing and tracing

Jan 25, 2021 9:32am
Once a broad swath of the population has been vaccinated, which could take many months, testing volume will likely drop off sharply. However ongoing outbreaks may require increased testing, particularly in poorer communities of color, which have been hit hardest by the pandemic. (Getty Images)
California Gov. Gavin Newsom, under growing pressure to jump-start a faltering COVID-19 vaccine rollout, jetted to Los Angeles on Jan. 15 to unveil a massive new vaccination site at Dodger Stadium that is expected eventually to inoculate 12,000 people a day.
The city-run venue had been the biggest COVID-19 testing site in the U.S., administering over 1 million tests in its nearly eight months of operation and over 10,000 a day during the recent surge. Its redeployment to the cause of vaccination, Newsom declared, provides “an extraordinary world-class site for a world-class logistics operation.” ....

Sierra Nevada , United States , Pierce College , Central Valley , San Diego County , San Fernando Valley , Madera County , San Bernardino County , Dodger Stadium , San Francisco , Corwin Porter , Bob Kocher , Eric Garcetti , Clemens Hong , George Rutherford , Joe Biden , Sara Bosse , Gavin Newsom , Sarah Sweeney , University Of California , Human Services Agency , Testing Task , University Of Southern California Schaeffer Center , Health Policy Economics , Los Angeles , Clinical Trials Summit ,

FDA rolls back N95 mask reuse to 4 decontamination cycles

Jan 25, 2021 7:25am
The FDA is reissuing 10 of its earliest authorizations from the past year, limiting each mask processed to a maximum of four decontaminations. (FDA)
The FDA has rolled back its emergency authorizations for N95 respirator decontamination systems, cutting down the number of times the agency said each mask could be safely reused.
During the early stages of the pandemic, when supplies of personal protective equipment and N95 filters were at a minimum, the FDA allowed masks to be reprocessed up to 20 times with certain hardware.
Systems produced by Battelle, Steris, Stryker and Advanced Sterilization Products kill viruses and bacteria by gassing them with hydrogen peroxide vapor in devices ranging from the refrigerator-sized to walk-in shipping containers. ....

Technical Safety Services , Michigan State University , Duke University , Advanced Sterilization Products , Clinical Trials Summit , Premier Educational Event Focused , Decentralized Clinical , Michigan State , Food And Drug Administration Fda , Corona Virus , Medical Device , Covid 19 , Face Mask , தொழில்நுட்ப பாதுகாப்பு சேவைகள் , மிச்சிகன் நிலை பல்கலைக்கழகம் , டியூக் பல்கலைக்கழகம் , மருத்துவ சோதனைகள் உச்சிமாநாடு , ப்ரிமியர் கல்வி நிகழ்வு கவனம் , மிச்சிகன் நிலை , கொரோனா வைரஸ் , மருத்துவ சாதனம் , முகம் முகமூடி ,